封面
市场调查报告书
商品编码
1272627

不孕治疗服务的全球市场的预测(~2027年)

Global Fertility Services Forecast to 2027

出版日期: | 出版商: Market Research Future | 英文 108 Pages | 订单完成后即时交付

价格

全球不孕治疗服务市场,主要由于压力水准的上升,肥胖,频繁的抽烟,环境变量,促进市场扩大。由于不安和忧郁症等生活方式的变化,过重,重度的酒精消费等多数的社会、环境的问题,不孕治疗服务存在很大的需求。

本报告提供全球不孕治疗服务市场相关调查分析,市场动态,地区和市场区隔的分析,企业简介等资讯。

目录

第1章 摘要整理

第2章 市场简介

第3章 调查手法

第4章 市场动态

  • 概要
  • 促进因素
    • 第一胎年龄的中位数上升和出生率低
    • 不孕治疗技术的进步
    • 肥胖的流行和酒精/香烟的消费增加
    • 促进因素的影响的分析
  • 阻碍因素
    • 先进国家市场的辅助生殖技术医疗的高治疗费用
    • 道德、社会疑虑
    • 阻碍因素的影响的分析
  • 机会
    • 对不孕治疗的偿付

第5章 市场要素的分析

  • 波特的五力分析
  • 价值链分析
    • 研究开发与设计
    • 製造
    • 流通
    • 行销和销售
    • 销售后监测
  • COVID-19影响的分析
    • 成长率的影响
    • 主要企业的影响
    • 主要地区的影响

第6章 全球不孕治疗服务市场:各根本原因

  • 概要
  • 女性的不孕
  • 男性的不孕

第7章 全球不孕治疗服务市场:各治疗类型

  • 概要
  • 辅助生殖技术技术(ART)
    • 体外受精(IVF)
    • 冻结胚置换(FER)
    • 人工授精
    • 其他
  • 不孕治疗药

第8章 全球不孕治疗服务市场:各地区

  • 概要
  • 欧洲
    • 西欧
    • 东欧
  • 南北美洲
    • 北美
    • 南美
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 其他的亚太地区
  • 中东、非洲
    • 中东
    • 非洲

第9章 竞争情形

  • 概要
  • 全球不孕治疗服务市场主要企业
  • 竞争基准
  • 竞争仪表板
  • 全球不孕治疗服务市场发展
    • 收购
    • 联盟
    • 扩张
    • 发展
    • 合资企业
    • 产品的销售/产品的认证

第10章 企业简介

  • MERCK KGAA
  • COOPERSURGICAL, INC.
  • CARE FERTILITY
  • FERRING BV.
  • INVO BIOSCIENCE
  • VITROLIFE
  • MONASH IVF GROUP
  • COOK
  • FUJIFILM IRVINE SCIENTIFIC
  • KITAZATO CORPORATION

第11章 附录

Product Code: MRFR/HS/4820-CR

Market Overview

The primary market drivers accelerating market expansion are rising levels of stress, obesity, frequent smoking, and environmental variables. There is a significant need for fertilization services as a result of a number of social and environmental issues, including lifestyle modifications such as anxiety or depression, overweight, and heavy alcohol consumption. For instance, 4% fewer children were born in the nation in 2020 compared to 2019, as per NPR, a semi media institution in the US. At 55.8 births per 1,000 women aged between 15 to 44, according to preliminary data, the total fertility rate reached yet another record low. When infertility rates rise, there will be a greater need for fertility services.

Segment Overview

Underlying reason, Therapy type, and Regional Insights are the three types of segment insights that make up Global Fertility Services.

Male and female infertility are included in the market segmentation for fertility services based on the underlying cause.

The market data for fertility services has been divided by medication taken into ART and insufficiency medications.

The high percentage is attributed to a rise in the infertile rate, increased awareness of fertility services, technological advancements, and supportive government initiatives.

Regional Analysis

The analysis offers market insights for North America, Europe, Asia-Pacific, and the rest of the world, by region. The market for fertility services in Europe, which had sales of $ 12.6871 billion in 2021, is anticipated to rise at a substantial CAGR throughout the study period. The high percentage is attributed to a rise in the failure rate, increased awareness of fertility services, technological advancements, and supportive government initiatives. For instance, per the European Society of Reproductive Biology and Embryology, the European Union does have the highest proportion of infertile in the world, affecting almost 25 million people. North America is expected to expand significantly during the projection period.

Major Players

The Global Fertility Service Sector is home to a variety of businesses, including the Irvine Scientific Company Inc., Cook Medical, Vitrolife, Monash IVF Group, Ferring B. V, Kitazato Cooperative, and Care Fertility, among others.

COVID 19 Impacts

The COVID-19 pandemic initially had a negative impact on the market for fertility services, but it quickly rebounded with a boost as many governments encouraged the restoration of infertility clinics, according to The Business Research Company's estimate of the worldwide fertility services industry. Since they followed the rules that were logistically feasible in their clinical setup, aligned their protocols with their hospital regulations, and was in agreement with the views of their clinical leaders, many people were seeking intending to go to infertility centres. Future COVID-19 immunisation rates are predicted to improve, which will benefit the market for fertility services because many nations are already in the unlocking stage and couples seeking treatment won't need to put off their plans. The rise in same-sex marriages is one of the main factors contributing to the market's explosive expansion, and it is anticipated that this trend will continue during the projection period. By using Partnership IVF, a type of IVF for lesbian couples that allows both partners to become physically active in the creation of their kid, same-sex couples will have a good impact on the IVF services. In this procedure, one partner provides the eggs, which are fertilised by sperm donation, and the other partner becomes pregnant. The market for fertility services will therefore grow as a result of the rise in same-sex unions.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

  • 1.1 OVERVIEW 13
    • 1.1.1 MARKET SYNOPSIS 13

2 MARKET INTRODUCTION

  • 2.1 SCOPE OF THE STUDY 14
  • 2.2 RESEARCH OBJECTIVE 14
  • 2.3 LIST OF ASSUMPTIONS & LIMITATIONS 14

3 RESEARCH METHODOLOGY

  • 3.1 OVERVIEW 16
  • 3.2 DATA MINING 16
  • 3.3 SECONDARY RESEARCH 17
  • 3.4 PRIMARY RESEARCH 18
    • 3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 18
    • 3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS 19
  • 3.5 FORECASTING TECHNIQUES 20
  • 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 21
    • 3.6.1 BOTTOM-UP APPROACH 22
    • 3.6.2 TOP-DOWN APPROACH 22
  • 3.7 DATA TRIANGULATION 23
  • 3.8 VALIDATION 23

4 MARKET DYNAMICS

  • 4.1 OVERVIEW 24
  • 4.2 DRIVERS 25
    • 4.2.1 GROWTH IN THE MEDIAN AGE OF FIRST-TIME MOTHERHOOD AND DECLINING FERTILITY RATE 25
    • 4.2.2 TECHNOLOGICAL ADVANCEMENTS IN FERTILITY TREATMENT 25
    • 4.2.3 INCREASING PREVALENCE OF OBESITY AND CONSUMPTION OF ALCOHOL/CIGARETTES 25
    • 4.2.4 DRIVERS IMPACT ANALYSIS 26
  • 4.3 RESTRAINTS 26
    • 4.3.1 HIGH PROCEDURAL COSTS OF ASSISTED REPRODUCTIVE TECHNIQUES IN DEVELOPED MARKETS 26
    • 4.3.2 ETHICAL AND SOCIAL CONCERNS 27
    • 4.3.3 RESTRAINTS IMPACT ANALYSIS 27
  • 4.4 OPPORTUNITIES 28
    • 4.4.1 REIMBURSEMENT FOR FERTILITY TREATMENTS 28

5 MARKET FACTOR ANALYSIS

  • 5.1 PORTER'S FIVE FORCES MODEL 29
    • 5.1.1 THREAT OF NEW ENTRANTS 29
    • 5.1.2 BARGAINING POWER OF SUPPLIERS 30
    • 5.1.3 THREAT OF SUBSTITUTES 30
    • 5.1.4 BARGAINING POWER OF BUYERS 30
    • 5.1.5 INTENSITY OF RIVALRY 30
  • 5.2 VALUE CHAIN ANALYSIS 31
    • 5.2.1 R&D AND DESIGNING 31
    • 5.2.2 MANUFACTURING 32
    • 5.2.3 DISTRIBUTION 32
    • 5.2.4 MARKETING & SALES 32
    • 5.2.5 POST-SALES MONITORING 32
  • 5.3 COVID-19 IMPACT ANALYSIS 33
    • 5.3.1 IMPACT ON GROWTH RATE 33
    • 5.3.2 IMPACT ON MAJOR PLAYERS 33
    • 5.3.3 IMPACT ON MAJOR REGIONS 33

6 GLOBAL FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE

  • 6.1 OVERVIEW 34
  • 6.2 FEMALE INFERTILITY 35
  • 6.3 MALE INFERTILITY 36

7 GLOBAL FERTILITY SERVICES MARKET, BY TREATMENT TYPE

  • 7.1 OVERVIEW 37
  • 7.2 ASSISTED REPRODUCTIVE TECHNOLOGY (ART) 38
    • 7.2.1 IN-VITRO FERTILIZATION (IVF) 39
    • 7.2.2 FROZEN EMBRYO REPLACEMENT (FER) 39
    • 7.2.3 ARTIFICIAL INSEMINATION 40
    • 7.2.4 OTHERS 40
  • 7.3 INFERTILITY DRUGS 41

8 GLOBAL FERTILITY SERVICES MARKET, BY REGION

  • 8.1 OVERVIEW 42
  • 8.2 EUROPE 43
    • 8.2.1 WESTERN EUROPE 45
      • 8.2.1.1 GERMANY 46
      • 8.2.1.2 UK 47
      • 8.2.1.3 FRANCE 48
      • 8.2.1.4 ITALY 49
      • 8.2.1.5 SPAIN 50
      • 8.2.1.6 REST OF WESTERN EUROPE 51
    • 8.2.2 EASTERN EUROPE 52
  • 8.3 AMERICAS 54
    • 8.3.1 NORTH AMERICA 56
      • 8.3.1.1 US 57
      • 8.3.1.2 CANADA 58
    • 8.3.2 LATIN AMERICA 59
  • 8.4 ASIA-PACIFIC 61
    • 8.4.1 JAPAN 62
    • 8.4.2 CHINA 63
    • 8.4.3 INDIA 64
    • 8.4.4 SOUTH KOREA 65
    • 8.4.5 AUSTRALIA 66
    • 8.4.6 REST OF ASIA PACIFIC 67
  • 8.5 MIDDLE EAST & AFRICA 69
    • 8.5.1 MIDDLE EAST 70
    • 8.5.2 AFRICA 71

9 COMPETITIVE LANDSCAPE

  • 9.1 OVERVIEW 73
  • 9.2 MAJOR PLAYERS IN THE GLOBAL FERTILITY SERVICES MARKET 73
  • 9.3 COMPETITIVE BENCHMARKING 74
  • 9.4 COMPETITOR DASHBOARD 75
  • 9.5 DEVELOPMENTS IN THE GLOBAL FERTILITY SERVICES MARKET 76
    • 9.5.1 ACQUISITION 76
    • 9.5.2 COLLABORATION 76
    • 9.5.3 EXPANSION 76
    • 9.5.4 DEVELOPMENT 77
    • 9.5.5 JOINT VENTURE 77
    • 9.5.6 PRODUCT LAUNCH/PRODUCT APPROVAL 77

10 COMPANY PROFILES

  • 10.1 MERCK KGAA 78
    • 10.1.1 COMPANY OVERVIEW 78
    • 10.1.2 FINANCIAL OVERVIEW 79
    • 10.1.3 PRODUCTS/SERVICES OFFERED 79
    • 10.1.4 KEY DEVELOPMENTS 80
    • 10.1.5 SWOT ANALYSIS 80
    • 10.1.6 KEY STRATEGIES 81
  • 10.2 COOPERSURGICAL, INC. 82
    • 10.2.1 COMPANY OVERVIEW 82
    • 10.2.2 FINANCIAL OVERVIEW 83
    • 10.2.3 PRODUCTS/SERVICES OFFERED 83
    • 10.2.4 KEY DEVELOPMENTS 84
    • 10.2.5 SWOT ANALYSIS 85
    • 10.2.6 KEY STRATEGIES 85
  • 10.3 CARE FERTILITY 86
    • 10.3.1 COMPANY OVERVIEW 86
    • 10.3.2 FINANCIAL OVERVIEW 86
    • 10.3.3 PRODUCTS/SERVICES OFFERED 86
    • 10.3.4 KEY DEVELOPMENTS 87
    • 10.3.5 SWOT ANALYSIS 87
    • 10.3.6 KEY STRATEGIES 87
  • 10.4 FERRING BV. 88
    • 10.4.1 COMPANY OVERVIEW 88
    • 10.4.2 FINANCIAL OVERVIEW 88
    • 10.4.3 PRODUCTS/SERVICES OFFERED 88
    • 10.4.4 KEY DEVELOPMENTS 89
    • 10.4.5 SWOT ANALYSIS 89
    • 10.4.6 KEY STRATEGIES 89
  • 10.5 INVO BIOSCIENCE 90
    • 10.5.1 COMPANY OVERVIEW 90
    • 10.5.2 FINANCIAL OVERVIEW 90
    • 10.5.3 PRODUCTS/SERVICES OFFERED 90
    • 10.5.4 KEY DEVELOPMENTS 91
    • 10.5.5 SWOT ANALYSIS 91
    • 10.5.6 KEY STRATEGIES 91
  • 10.6 VITROLIFE 92
    • 10.6.1 COMPANY OVERVIEW 92
    • 10.6.2 FINANCIAL OVERVIEW 92
    • 10.6.3 PRODUCTS/SERVICES OFFERED 93
    • 10.6.4 KEY DEVELOPMENTS 94
    • 10.6.5 SWOT ANALYSIS 95
    • 10.6.6 KEY STRATEGIES 95
  • 10.7 MONASH IVF GROUP 96
    • 10.7.1 COMPANY OVERVIEW 96
    • 10.7.2 FINANCIAL OVERVIEW 96
    • 10.7.3 PRODUCTS/SERVICES OFFERED 97
    • 10.7.4 KEY DEVELOPMENTS 97
    • 10.7.5 SWOT ANALYSIS 98
    • 10.7.6 KEY STRATEGIES 98
  • 10.8 COOK 99
    • 10.8.1 COMPANY OVERVIEW 99
    • 10.8.2 FINANCIAL OVERVIEW 99
    • 10.8.3 PRODUCTS/SERVICES OFFERED 99
    • 10.8.4 KEY DEVELOPMENTS 100
    • 10.8.5 SWOT ANALYSIS 101
    • 10.8.6 KEY STRATEGIES 101
  • 10.9 FUJIFILM IRVINE SCIENTIFIC 102
    • 10.9.1 COMPANY OVERVIEW 102
    • 10.9.2 FINANCIAL OVERVIEW 102
    • 10.9.3 PRODUCTS/SERVICES OFFERED 103
    • 10.9.4 KEY DEVELOPMENTS 103
    • 10.9.5 SWOT ANALYSIS 104
    • 10.9.6 KEY STRATEGIES 104
  • 10.10 KITAZATO CORPORATION 105
    • 10.10.1 COMPANY OVERVIEW 105
    • 10.10.2 FINANCIAL OVERVIEW 105
    • 10.10.3 PRODUCTS/SERVICES OFFERED 105
    • 10.10.4 KEY DEVELOPMENTS 106
    • 10.10.5 SWOT ANALYSIS 106
    • 10.10.6 KEY STRATEGIES 106

11 APPENDIX

  • 11.1 REFERENCES 107
  • 11.2 RELATED REPORTS 107

LIST OF TABLES

  • TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS 14
  • TABLE 2 GLOBAL FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 34
  • TABLE 3 GLOBAL FERTILITY SERVICES MARKET FOR FEMALE INFERTILITY, BY REGION, 2020-2027 (USD MILLION) 35
  • TABLE 4 GLOBAL FERTILITY SERVICES MARKET FOR MALE INFERTILITY, BY REGION, 2020-2027 (USD MILLION) 36
  • TABLE 5 GLOBAL FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 37
  • TABLE 6 GLOBAL FERTILITY SERVICES MARKET FOR ART, BY TYPE, 2020-2027 (USD MILLION) 38
  • TABLE 7 GLOBAL FERTILITY SERVICES MARKET FOR ART TREATMENT, BY REGION, 2020-2027 (USD MILLION) 39
  • TABLE 8 GLOBAL FERTILITY SERVICES MARKET FOR IN-VITRO FERTILIZATION (IVF), BY REGION, 2020-2027 (USD MILLION) 39
  • TABLE 9 GLOBAL FERTILITY SERVICES MARKET FOR FROZEN EMBRYO REPLACEMENT (FER), BY REGION, 2020-2027 (USD MILLION) 39
  • TABLE 10 GLOBAL FERTILITY SERVICES MARKET FOR ARTIFICIAL INSEMINATION, BY REGION, 2020-2027 (USD MILLION) 40
  • TABLE 11 GLOBAL FERTILITY SERVICES MARKET FOR OTHERS, BY REGION, 2020-2027 (USD MILLION) 40
  • TABLE 12 GLOBAL FERTILITY SERVICES MARKET FOR INFERTILITY DRUGS, BY REGION, 2020-2027 (USD MILLION) 41
  • TABLE 13 GLOBAL FERTILITY SERVICES MARKET, BY REGION, 2020-2027 (USD MILLION) 42
  • TABLE 14 EUROPE: FERTILITY SERVICES MARKET, BY REGION, 2020-2027 (USD MILLION) 43
  • TABLE 15 EUROPE: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 44
  • TABLE 16 EUROPE: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 44
  • TABLE 17 EUROPE: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 44
  • TABLE 18 WESTERN EUROPE: FERTILITY SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 45
  • TABLE 19 WESTERN EUROPE: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 45
  • TABLE 20 WESTERN EUROPE: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 46
  • TABLE 21 WESTERN EUROPE: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 46
  • TABLE 22 GERMANY: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 46
  • TABLE 23 GERMANY: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 46
  • TABLE 24 GERMANY: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 47
  • TABLE 25 UK: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 47
  • TABLE 26 UK: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 47
  • TABLE 27 UK: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 48
  • TABLE 28 FRANCE: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 48
  • TABLE 29 FRANCE: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 48
  • TABLE 30 FRANCE: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 49
  • TABLE 31 ITALY: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 49
  • TABLE 32 ITALY: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 49
  • TABLE 33 ITALY: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 50
  • TABLE 34 SPAIN: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 50
  • TABLE 35 SPAIN: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 50
  • TABLE 36 SPAIN: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 51
  • TABLE 37 REST OF WESTERN EUROPE: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 51
  • TABLE 38 REST OF WESTERN EUROPE: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 51
  • TABLE 39 REST OF WESTERN EUROPE: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 52
  • TABLE 40 EASTERN EUROPE: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 52
  • TABLE 41 EASTERN EUROPE: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 52
  • TABLE 42 EASTERN EUROPE: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 53
  • TABLE 43 AMERICAS: FERTILITY SERVICES MARKET, BY REGION, 2020-2027 (USD MILLION) 54
  • TABLE 44 AMERICAS: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 55
  • TABLE 45 AMERICAS: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 55
  • TABLE 46 AMERICAS: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 55
  • TABLE 47 NORTH AMERICA: FERTILITY SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 56
  • TABLE 48 NORTH AMERICA: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 56
  • TABLE 49 NORTH AMERICA: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 56
  • TABLE 50 NORTH AMERICA: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 57
  • TABLE 51 US: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 57
  • TABLE 52 US: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 57
  • TABLE 53 US: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 58
  • TABLE 54 CANADA: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 58
  • TABLE 55 CANADA: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 58
  • TABLE 56 CANADA: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 59
  • TABLE 57 LATIN AMERICA: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 59
  • TABLE 58 LATIN AMERICA: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 59
  • TABLE 59 LATIN AMERICA: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 60
  • TABLE 60 ASIA-PACIFIC: FERTILITY SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 61
  • TABLE 61 ASIA-PACIFIC: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 62
  • TABLE 62 ASIA-PACIFIC: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 62
  • TABLE 63 ASIA-PACIFIC: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 62
  • TABLE 64 JAPAN: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 62
  • TABLE 65 JAPAN: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 63
  • TABLE 66 JAPAN: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 63
  • TABLE 67 CHINA: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 63
  • TABLE 68 CHINA: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 63
  • TABLE 69 CHINA: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 64
  • TABLE 70 INDIA: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 64
  • TABLE 71 INDIA: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 64
  • TABLE 72 INDIA: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 65
  • TABLE 73 SOUTH KOREA: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 65
  • TABLE 74 SOUTH KOREA: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 65
  • TABLE 75 SOUTH KOREA: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 66
  • TABLE 76 AUSTRALIA: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 66
  • TABLE 77 AUSTRALIA: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 66
  • TABLE 78 AUSTRALIA: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 67
  • TABLE 79 REST OF ASIA-PACIFIC: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 67
  • TABLE 80 REST OF ASIA-PACIFIC: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 67
  • TABLE 81 REST OF ASIA-PACIFIC: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 68
  • TABLE 82 MIDDLE EAST & AFRICA: FERTILITY SERVICES MARKET, BY REGION, 2020-2027 (USD MILLION) 69
  • TABLE 83 MIDDLE EAST & AFRICA: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 69
  • TABLE 84 MIDDLE EAST & AFRICA: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 70
  • TABLE 85 MIDDLE EAST & AFRICA: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 70
  • TABLE 86 MIDDLE EAST: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 70
  • TABLE 87 MIDDLE EAST: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 70
  • TABLE 88 MIDDLE EAST: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 71
  • TABLE 89 AFRICA: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 71
  • TABLE 90 AFRICA: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 71
  • TABLE 91 AFRICA: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 72
  • TABLE 92 MAJOR PLAYERS IN THE GLOBAL FERTILITY SERVICES MARKET 73
  • TABLE 93 COMPETITOR DASHBOARD: GLOBAL FERTILITY SERVICES MARKET 75
  • TABLE 94 ACQUISITION 76
  • TABLE 95 COLLABORATION 76
  • TABLE 96 EXPANSION 76
  • TABLE 97 DEVELOPMENT 77
  • TABLE 98 JOINT VENTURE 77
  • TABLE 99 PRODUCT LAUNCH/PRODUCT APPROVAL 77
  • TABLE 100 MERCK KGAA: PRODUCTS/SERVICES OFFERED 79
  • TABLE 101 MERCK KGAA: KEY DEVELOPMENTS 80
  • TABLE 102 COOPERSURGICAL, INC.: PRODUCTS/SERVICES OFFERED 83
  • TABLE 103 COOPERSURGICAL, INC.: KEY DEVELOPMENTS 84
  • TABLE 104 CARE FERTILITY: PRODUCTS/SERVICES OFFERED 86
  • TABLE 105 FERRING BV: PRODUCTS/SERVICES OFFERED 88
  • TABLE 106 FERRING BV: KEY DEVELOPMENTS 89
  • TABLE 107 INVO BIOSCIENCE: PRODUCTS/SERVICES OFFERED 90
  • TABLE 108 INVO BIOSCIENCE: KEY DEVELOPMENTS 91
  • TABLE 109 VITROLIFE: PRODUCTS/SERVICES OFFERED 93
  • TABLE 110 VITROLIFE: KEY DEVELOPMENTS 94
  • TABLE 111 MONASH IVF GROUP: PRODUCTS/SERVICES OFFERED 97
  • TABLE 112 MONASH IVF GROUP: KEY DEVELOPMENTS 97
  • TABLE 113 COOK: PRODUCTS/SERVICES OFFERED 99
  • TABLE 114 COOK: KEY DEVELOPMENTS 100
  • TABLE 115 FUJIFILM IRVINE SCIENTIFIC: PRODUCTS/SERVICES OFFERED 103
  • TABLE 116 FUJIFILM IRVINE SCIENTIFIC: KEY DEVELOPMENTS 103
  • TABLE 117 KITAZATO CORPORATION: PRODUCTS/SERVICES OFFERED 105
  • TABLE 118 KITAZATO CORPORATION: KEY DEVELOPMENTS 106

LIST OF FIGURES

  • FIGURE 1 GLOBAL FERTILITY SERVICES MARKET STRUCTURE 15
  • FIGURE 2 BOTTOM-UP AND TOP-DOWN APPROACHES 21
  • FIGURE 3 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL FERTILITY SERVICES MARKET 24
  • FIGURE 4 PORTER'S FIVE FORCES ANALYSIS: GLOBAL FERTILITY SERVICES MARKET 29
  • FIGURE 5 VALUE CHAIN ANALYSIS OF THE GLOBAL FERTILITY SERVICES MARKET 31
  • FIGURE 6 GLOBAL FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020 & 2027 (USD MILLION) 34
  • FIGURE 7 GLOBAL FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020 & 2027 (USD MILLION) 37
  • FIGURE 8 GLOBAL FERTILITY SERVICES MARKET FOR ART, BY TREATMENT TYPE, 2020 & 2027 (USD MILLION) 38
  • FIGURE 9 GLOBAL FERTILITY SERVICES MARKET, BY REGION, 2020 & 2027 (USD MILLION) 42
  • FIGURE 10 EUROPE: FERTILITY SERVICES MARKET SHARE, BY REGION 2020 (%) 43
  • FIGURE 11 WESTERN EUROPE: FERTILITY SERVICES MARKET SHARE, BY COUNTRY, 2020 (%) 45
  • FIGURE 12 AMERICAS: FERTILITY SERVICES MARKET SHARE, BY REGION, 2020 (%) 54
  • FIGURE 13 NORTH AMERICA: FERTILITY SERVICES MARKET SHARE, BY COUNTRY, 2020 (%) 56
  • FIGURE 14 ASIA-PACIFIC: FERTILITY SERVICES MARKET SHARE, BY COUNTRY, 2020 (%) 61
  • FIGURE 15 MIDDLE EAST & AFRICA: FERTILITY SERVICES MARKET SHARE, BY REGION, 2020 (%) 69
  • FIGURE 16 BENCHMARKING OF MAJOR COMPETITORS 74
  • FIGURE 17 MERCK KGAA: FINANCIAL OVERVIEW SNAPSHOT 79
  • FIGURE 18 MERCK KGAA: SWOT ANALYSIS 80
  • FIGURE 19 COOPERSURGICAL, INC.: FINANCIAL OVERVIEW SNAPSHOT 83
  • FIGURE 20 COOPERSURGICAL, INC.: SWOT ANALYSIS 85
  • FIGURE 21 CARE FERTILITY: SWOT ANALYSIS 87
  • FIGURE 22 FERRING BV: SWOT ANALYSIS 89
  • FIGURE 23 INVO BIOSCIENCE: FINANCIAL OVERVIEW SNAPSHOT 90
  • FIGURE 24 INVO BIOSCIENCE: SWOT ANALYSIS 91
  • FIGURE 25 VITROLIFE: FINANCIAL OVERVIEW SNAPSHOT 92
  • FIGURE 26 VITROLIFE: SWOT ANALYSIS 95
  • FIGURE 27 MONASH IVF GROUP: FINANCIAL OVERVIEW SNAPSHOT 96
  • FIGURE 28 MONASH IVF GROUP: SWOT ANALYSIS 98
  • FIGURE 29 COOK: SWOT ANALYSIS 101
  • FIGURE 30 FUJIFILM IRVINE SCIENTIFIC: FINANCIAL OVERVIEW SNAPSHOT 102
  • FIGURE 31 FUJIFILM IRVINE SCIENTIFIC: SWOT ANALYSIS 104
  • FIGURE 32 KITAZATO CORPORATION: SWOT ANALYSIS 106